Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sina Heimer

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Injury|December 22, 2011
Extracorporeal shock wave treatment protects skin flaps against ischemia-reperfusion injuryMatthias A Reichenberger, Sina Heimer, Amelia Schaefer, et al.
Frontiers in Oncology|August 27, 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinomaVerena Schweihofer, Daniela Schulz, Raquel Blazquez, et al.
Molecular Oncology|December 16, 2023
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacyDaniela Schulz, Laura Feulner, Dominique Santos Rubenich, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Injury|December 22, 2011
Extracorporeal shock wave treatment protects skin flaps against ischemia-reperfusion injuryMatthias A Reichenberger, Sina Heimer, Amelia Schaefer, et al.
Frontiers in Oncology|August 27, 2025
Multiplexed immune profiling and 3D co-culture assays to assess the individual checkpoint therapy response in head and neck squamous cell carcinomaVerena Schweihofer, Daniela Schulz, Raquel Blazquez, et al.
Molecular Oncology|December 16, 2023
Subcellular localization of PD-L1 and cell-cycle-dependent expression of nuclear PD-L1 variants: implications for head and neck cancer cell functions and therapeutic efficacyDaniela Schulz, Laura Feulner, Dominique Santos Rubenich, et al.
Pageof 2